Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Skeletal Radiol ; 52(12): 2497-2501, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-37544967

RESUMO

Chondromyxoid fibroma is a rare, benign tumor of the bone with excellent prognosis but a high rate of recurrence. We report a patient presenting with pain and a history of chondromyxoid fibroma of the distal left femur previously treated with multiple prior curettage and bone graft procedures. Magnetic resonance imaging and histopathology indicated a recurrence of tumor. Due to the small size of the tumor recurrence and challenges associated with prior open surgery, the patient underwent cryoablation of the lesion with computed tomography guidance. Follow-up 18 months later indicated a resolution of pain and improvement on magnetic resonance imaging, and no concerns after 20 months. To our knowledge, this is the first reported case of chondromyxoid fibroma treated with cryoablation. This case suggests cryoablation could be considered in the setting of recurrent chondromyxoid fibroma for local tumor control.


Assuntos
Neoplasias Ósseas , Condromatose , Criocirurgia , Fibroma , Humanos , Neoplasias Ósseas/diagnóstico por imagem , Neoplasias Ósseas/cirurgia , Neoplasias Ósseas/patologia , Recidiva Local de Neoplasia/diagnóstico por imagem , Recidiva Local de Neoplasia/cirurgia , Fibroma/diagnóstico por imagem , Fibroma/cirurgia , Fibroma/patologia , Fêmur/diagnóstico por imagem , Fêmur/cirurgia , Fêmur/patologia , Dor/cirurgia
2.
Vasc Endovascular Surg ; 55(8): 885-888, 2021 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-34114524

RESUMO

Portal vein aneurysm (PVA) is a rare entity that can lead to hemorrhage or thrombosis. Although there is no standard treatment, most cases can be managed conservatively; intervention is reserved for symptomatic or enlarging aneurysms. For patients who are not surgical candidates due to cirrhosis and portal hypertension, endovascular creation of a trans-jugular intrahepatic porto-systemic shunt (TIPS) is an option to reduce portal venous pressure. This report describes a case of an enlarging PVA successfully treated with TIPS in a patient with cryptogenic cirrhosis.


Assuntos
Aneurisma , Hipertensão Portal , Derivação Portossistêmica Transjugular Intra-Hepática , Aneurisma/diagnóstico por imagem , Aneurisma/cirurgia , Humanos , Hipertensão Portal/diagnóstico por imagem , Hipertensão Portal/etiologia , Hipertensão Portal/cirurgia , Veia Porta/diagnóstico por imagem , Veia Porta/cirurgia , Resultado do Tratamento
3.
Clin Imaging ; 69: 169-171, 2021 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-32861127

RESUMO

Spontaneous breast hematoma is a rare complication of therapeutic anticoagulation therapy with few cases reported in the literature. We present a case of spontaneous breast hematoma resulting in hypotension and symptomatic anemia. Angiography demonstrated multiple sites of hemorrhage within the breast, which was treated with gelatin sponge embolization. This case highlights the role of interventional radiology in the treatment of breast hematoma, as well as reviews the arterial vascular anatomy of the breast.


Assuntos
Embolização Terapêutica , Hematoma , Angiografia , Anticoagulantes/efeitos adversos , Mama/diagnóstico por imagem , Embolização Terapêutica/efeitos adversos , Hematoma/induzido quimicamente , Hematoma/diagnóstico por imagem , Humanos
4.
J Surg Case Rep ; 2016(10)2016 Oct 07.
Artigo em Inglês | MEDLINE | ID: mdl-27765805

RESUMO

Kayexalate is an ion exchange resin that is commonly used to acutely treat patients with hyperkalemia. Bowel ulceration and necrosis is a rare and uncommonly recognized complication of kayexalate administration. More often, concomitant administration with sorbitol is reported to damage the bowel; however, there are reports of kayexalate administration causing bowel necrosis without sorbitol. We present a case of a critically ill patient who underwent total colectomy for colonic necrosis secondary to oral kayexalate administration that was not recognized until late in the pathologic process. We also review the literature to further investigate this progression.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA